India Rating reaffirms rating of Claris Lifesciences’ bank facilities

20 Mar 2015 Evaluate

Credit rating agency, India Rating & Research (Ind- Ra) has affirmed ‘A’ rating with a ‘Stable’ outlook to long term bank facilities to Claris Lifesciences. Since all the working capital and term loans have been transferred to Claris Injectables (CIL), the agency has withdrawn the ratings of the short term / long term loan instruments of CLL. However the same ratings have been assigned to CIL instruments.

Claris Lifesciences is one of the few injectables companies in India to have its own front end in the US, the company markets its products through its wholly owned subsidiary Claris Lifesciences Inc. The company now has 11 ANDAs approved and has a total filing of 32 ANDAs.

 

Peers
Company Name CMP
Redington 263.75
Adani Enterprises 2255.00
Amrapali Industries 15.37
Rashi Peripheral 317.45
PDS 341.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×